U.S. Food and Drug Administration Operations Manager Salaries in Gulfport-Biloxi, MS
The average U.S. Food and Drug Administration Operations Manager in Gulfport-Biloxi, MS earns an estimated $122,400 annually, which includes an estimated base salary of $103,557 with a $18,842 bonus. U.S. Food and Drug Administration's Operations Manager compensation is $9,380 more than the US average for a Operations Manager. Operations Manager salaries at U.S. Food and Drug Administration in Gulfport-Biloxi, MS can range from $32,000 - $316,000.
In Gulfport-Biloxi, MS, The Operations Department at U.S. Food and Drug Administration earns $9,718 more on average than the Finance Department.
Last updated 3 years ago.
- $103,557
- avg. base
- $18,842
- avg. bonus
Operations Manager Salaries at U.S. Food and Drug Administration
In Gulfport-Biloxi, MS, Operations Managers earn $4,265 more than Operations Managers, and $56,372 less than Directors of Operations.
Compensation at U.S. Food and Drug Administration by Department
In Gulfport-Biloxi, MS, The Operations Department averages $9,718 more than the Finance Department, and $5,200 less than the Marketing Department
Operations Manager Compensation by Gender (All Companies)
The average female Operations Manager at companies similar size to U.S. Food and Drug Administration reported making $115,602, while the average male Operations Manager at similar sized companies reported making $119,495.
Operations Manager Compensation by Ethnicity (All Companies)
The average Asian or Pacific Islander Operations Manager at companies similar size to U.S. Food and Drug Administration reported making $131,364, while the average African American/Black Operations Manager at similar sized companies reported making $94,441.
How Operations Managers at U.S. Food and Drug Administration Rate Their Compensation
The majority of Operations Managers at U.S. Food and Drug Administration believe they're compensated fairly. 100% of Operations Managers at U.S. Food and Drug Administration say they receive annual bonuses, and the vast majority (71%) are satisfied with their benefits. See more compensation ratings at U.S. Food and Drug Administration
